Syneos Health Stock Price, News & Analysis

SYNH NASDAQ

Company Description

Syneos Health (NASDAQ: SYNH) is a publicly traded research and development in biotechnology company in the Professional, Scientific, and Technical Services sector.

SYNH stock has declined 100.0% over the past year.

This page provides a comprehensive overview of SYNH stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-100%

Performance 1 year

$0.0

Market Cap

103.7M

Shares outstanding

Syneos Health (SYNH) stock. Over the past 12 months, the stock has lost 100.0%.

Latest News

View All

April 29, 2024

0.00%

Mitsubishi Tanabe Pharma America Celebrates Eight-Year Anniversary in the U.S.

April 12, 2024

0.00%

Mitsubishi Tanabe Pharma America to Showcase Breadth of Neurodegenerative Research at 2024 American Academy of Neurology Annual Meeting

April 8, 2024

0.00%

Mitsubishi Tanabe Pharma America Receives U.S. Food and Drug Administration Orphan Drug Exclusivity for RADICAVA ORS® (edaravone)

September 28, 2023

0.00%

Syneos Health Closes Transaction with Private Investment Firms

September 26, 2023

+0.44%

Syneos Health Names Terttu Haring President, Clinical Sites & Patients

September 12, 2023

-0.05%

Syneos Health and Oracle to Expand Relationship to Accelerate Patient Recruitment & Advance Health Equity

Syneos Health has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 3 with negative movement. Key topics include partnership, clinical trial. View all SYNH news →

SEC Filings

View All

No SEC filings available for SYNH.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

SYNH Company Profile & Sector Positioning

Syneos Health (SYNH) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the NASDAQ.